Dr Goode is a Group Leader in the Computational Cancer Biology Program, where he heads the Evolutionary Cancer Genomics group.

His research applies bioinformatics, molecular evolution and population genetics to large cancer genomics data sets to study the evolutionary forces governing the formation of tumours and their responses to therapy.

All projects in his group are highly collaborative, teaming with a number of leading laboratory and clinical researchers at the Peter Mac, WEHI, Monash University and beyond. We have a particular interest in single-cell biology of tumours and how transcriptional heterogeneity drives disease progression and therapy resistance in cancer.

There is a strong focus on prostate cancer but the group operates across a number of other tumour types as well, including glioblastoma and acute myeloid leukemia. Our work has appeared in numerous high-profile journals, including Nature Communications, PNAS, eLife and Genome Medicine.

Dr Goode is supported by the Peter MacCallum Cancer Foundation, the Victorian Cancer Agency and the CASS Foundation.